Amrize Ltd. (AMRZ) intrinsic value & 10-year financials
Amrize Ltd. (AMRZ) has a Graham intrinsic value of $17.87 per share. At $37.82 on Oct 17, 2026, the stock trades 112% above that value. Over the last 4 fiscal years revenue grew 0.6% a year to $11.8B, with an average return on invested capital of 16.2%.
- Graham intrinsic value
- $17.87
- Share price (Oct 17, 2026)
- $37.82
- Price vs Graham value
- 112% above
- Market cap
- $20.9B
- Revenue (FY2025)
- $11.8B
- Revenue growth (4-yr CAGR)
- 0.6%
- ROIC (10-yr avg)
- 16.2%
- Free cash flow (FY2025)
- $1.4B
AMRZ 10-year financial history
| Fiscal year | Revenue | Net income | EPS (diluted) | Free cash flow | Operating margin | ROIC |
|---|---|---|---|---|---|---|
| FY2025 | $11.8B | $1.2B | $2.14 | $1.4B | 16.1% | 14.1% |
| FY2024 | $11.7B | $1.3B | $2.30 | $1.6B | 18.8% | 18.9% |
| FY2023 | $11.7B | $956.0M | $1.73 | $1.4B | 16.2% | 15.7% |
| FY2022 | — | — | — | — | — | — |
Source: annual 10-K filings on SEC EDGAR. Figures in USD.
Executive summary
Amrize Ltd revenue growth over the past decade is N/A; insufficient history prevents a reliable 10-year CAGR calculation.
Amrize Ltd has earned high returns on invested capital, averaging 16.2% ROIC over the available history. High ROIC is consistent with a durable franchise, but it is not by itself proof of an economic moat.
Amrize Ltd capital allocation metrics are N/A for the decade; share count and net debt history are incomplete.
Benjamin Graham lens
Under Benjamin Graham's formula using SEC EDGAR fundamentals, Amrize Ltd is modeled at 0.6% normalized earnings growth with a 5.1% bond-yield adjustment. The resulting Graham intrinsic value estimate is $17.87 per share.